Unique Total-Body Imaging Scanner uEXPLORER Cleared by FDA
The uEXPLORER combines positron emission tomography (PET) with X-ray computed tomography (CT) allowing for imaging of the entire body at the same time.
Imaging Agents
Artificial Intelligence can Detect, Classify Acute Brain Bleeds
An artificial intelligence system can diagnose and classify intracranial hemorrhage (ICH).
MRI Indicates Sacroiliitis in Some Healthy Individuals
Healthy volunteers, patients with chronic back pain, and runners did not have deep bone marrow edema lesions, but 89.4% of axial SpA patients and 14.3% of women with postpartum back pain did have lesions.
Chest Radiograph Effective for Excluding Pediatric Pneumonia
The researchers found that 72.8% of children had negative CXRs, with 8.9% of these children clinically diagnosed with pneumonia and 9.3% given antibiotics for other bacterial syndromes.
Biomarker Panel May Improve Lung Cancer Risk Assessment
The integrated risk prediction model combining smoking exposure with the biomarker score yielded an area under the curve of 0.83 versus 0.73 for a model based on smoking exposure alone.
Post-Endoscopic Infection More Common Than Previously Thought
The rates of infections were compared with those after screening mammography, prostate cancer screening, bronchoscopy, and cystoscopy procedures.
FDA: New Med Guide for Patients Receiving Gadolinium-Based Contrast Agents
These Medication Guides should be provided the first time an outpatient receives a GBCA injection at an MRI center; hospital patients are not required to receive a Medication Guide.
Kurtosis Diffusion-Weighted Imaging May Reduce False Positive Mammographies
At the predefined sensitivity of greater than 98.0%, the researchers found that the radiomics feature model reduced false-positive results from 66 to 20 in the independent test set (specificity, 70.0%); BI-RADS 4a and 4b lesions benefited from the analysis (74.0 and 60.0%, respectively).
FDA: ‘Groundbreaking’ Approval Enables Domestic Supply of Critical Medical Isotope
New technology approved to produce the country’s own supply of the radioisotope Technetium-99m
FDA Expands Pediatric Age Range for MultiHance Contrast Agent
The FDA’s approval was supported by data specifically gathered in patients aged <2 years. The 0.1mmol/kg dose significantly improved the visualization and morphologic assessment of CNS lesions as seen in older pediatric patients and adults.
